Aghakhani Nozar
Department of Neurosurgery, Center for Evaluation and Multidisciplinary Care of the Mild Traumatic Brain Injury, Bicêtre University Hospital, Le Kremlin-Bicêtre, France.
J Neurosci Res. 2022 Mar;100(3):827-834. doi: 10.1002/jnr.25004. Epub 2021 Dec 29.
There is increasing evidence for the important role of gut microbiota (GMB) in the development and progression of neurologic pathologies. Some studies have shown that modifying the microbiome profile can confer benefits to patients. Mild traumatic brain injury (mTBI) is a common occurrence in the general population. Although most patients recover, in a minority, disabling symptoms can persist for several months. We carried out a review of the literature to assess the effect of mTBI on GMB and to determine whether alleviating dysbiosis can improve clinical outcomes in mTBI patients. We performed searches in Medline/PubMed and Embase using the keywords "MTBI" AND "microbiome" OR "microbiota". Additional articles were identified by manual searches and using the Google search engine. In animal models, a clear perturbation of GMB was reported following TBI and probiotic supplementation (Lactobacillus acidophilus or Clostridium butyricum) improved neurologic function. There were no studies on changes in GMB after mTBI in humans; however, pre- or probiotic supplementation reduced the infection rate in patients with severe TBI and shortened the time spent in the intensive care unit without conferring any neurologic benefits. Thus, although the findings from animal models are promising, clinical studies are needed to determine whether therapeutic strategies that restore gut microbiome profile can improve long-term outcomes of patients with mTBI.
越来越多的证据表明肠道微生物群(GMB)在神经病理学的发展和进程中起着重要作用。一些研究表明,改变微生物组特征可为患者带来益处。轻度创伤性脑损伤(mTBI)在普通人群中很常见。尽管大多数患者会康复,但少数患者的致残症状可能会持续数月。我们对文献进行了综述,以评估mTBI对GMB的影响,并确定缓解生态失调是否能改善mTBI患者的临床结局。我们在Medline/PubMed和Embase中使用关键词“MTBI”和“微生物组”或“微生物群”进行检索。通过手动检索和使用谷歌搜索引擎确定了其他文章。在动物模型中,TBI后报告了GMB的明显扰动,补充益生菌(嗜酸乳杆菌或丁酸梭菌)可改善神经功能。尚无关于人类mTBI后GMB变化的研究;然而,补充益生元或益生菌可降低重度TBI患者的感染率,并缩短在重症监护病房的时间,但未带来任何神经方面的益处。因此,尽管动物模型的研究结果很有前景,但仍需要进行临床研究来确定恢复肠道微生物组特征的治疗策略是否能改善mTBI患者的长期结局。